Peridol Injection (Haloperidol)

Adult dosage

○ Adults 1. Schizophrenia, manic episodes associated with bipolar I disorder, symptoms of psychotic disorders, Tourette syndrome (Gilles de la Tourette's syndrome): Administer 6-15㎎ per day of this drug by intramuscular injection in divided doses, and switch to oral administration as soon as possible. Dosage may be adjusted according to age and symptoms. 2. Adjunctive treatment of postoperative nausea and vomiting when other drugs are ineffective or not tolerated: Administer 1-2mg of haloperidol by intramuscular injection as a single dose.

Caution should be exercised as this medication may increase the risk of death when treating psychotic symptoms related to cognitive dysfunction in elderly patients. During the administration of this medication, cardiac arrhythmias may occur, especially QT interval prolongation and severe arrhythmias, so the condition should be monitored regularly through electrocardiograms. This medication is not used for intravenous injection; if intravenous administration is necessary, more stringent cardiac monitoring is required. In patients at high risk for cerebrovascular disease, the risk of stroke may increase when using this medication, so it should be administered with caution. There is a risk of thrombosis during the use of this medication, so patients with thrombotic risk factors should identify risk factors in advance and take preventive measures. Ampoule injectables should be handled carefully to avoid contamination with glass particles, particularly in children and the elderly. This medication should not be administered to those with hypersensitivity to it, in comatose states, severe heart failure, Parkinson's disease, certain dementia patients, pregnant women, etc. Patients with impaired liver or kidney function, cardiovascular diseases, or seizure disorders should use this medication more cautiously. This medication can cause various side effects, so blood pressure, electrocardiograms, liver function, blood tests, etc., should be monitored regularly during administration, and immediate action should be taken if abnormal symptoms arise. Drowsiness or dizziness may occur, so driving or operating hazardous machinery should be avoided, and abrupt cessation of the medication may result in withdrawal symptoms, so it should be tapered gradually. This medication can interact with other drugs, so if there are any co-administered medications, it must be reported to the healthcare provider, especially when combined with medications affecting the heart. Pregnant or nursing women should not take this medication, and women of childbearing potential should be confirmed before administration. Children and the elderly are at a higher risk of side effects, so dosage adjustment and careful monitoring are necessary. In the case of overdose, severe cardiac issues, hypotension, sedation, etc., may occur, so immediate treatment at a medical institution is required. This medication is administered as an injection only when oral administration is difficult and should be transitioned to oral administration as soon as possible.

increased mortality, acute death, QT prolongation, Torsades de Pointes, hypotension, hypertension, tachycardia, ventricular tachycardia, thromboembolism, motor paralysis, severe muscle rigidity, dysphagia, sweating, fever, leukocytosis, serum CPK elevation, myoglobinuria, decreased kidney function, high fever, altered consciousness, dyspnea, circulatory collapse, dehydration symptoms, acute renal failure, acute muscle tension disorder, opisthotonos, trismus, Parkinsonian rigidity, tremor, inability to move, inability to sit, irreversible involuntary stereotyped movement disorder syndrome, abnormal movement, delayed movement disorder, hepatitis, jaundice, liver dysfunction, retinitis, cataract, impaired eye accommodation, blurred vision, corneal opacity, lens opacity, corneal pigmentation, edema, erythema, urticarial, exfoliative dermatitis, photosensitivity, anaphylactic reaction, hypersensitivity vasculitis, bronchospasm, laryngospasm, anemia, leukocytosis, leukopenia, erythrocytopenia, agranulocytosis, loss of appetite, nausea, vomiting, constipation, diarrhea, intestinal paralysis, paralytic ileus, hyperprolactinemia, female breast enlargement, milk secretion, menstrual irregularities, changes in libido, hyperglycemia, hypoglycemia, weight gain, weight loss, hyponatremia, hypotonemic hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, bronchial spasm, laryngeal spasm, dyspnea, insomnia, restlessness, drowsiness, dizziness, headache, heaviness in the head, anxiety, depression, hallucination, agitation, thirst, nasal congestion, lethargy, urinary retention, fever, sweating, flushing, hypothermia

This medication should be stored in a sealed container to protect it from air and light exposure. It is also advisable to store it at room temperature away from direct sunlight.

Appearance

A brown ampoule containing a colorless and transparent liquid.

Package unit

1 ampoule (1 mL) × 10 1 ampoule (1 mL) × 50